Comparative analysis of clinicopathological correlations of cyclooxygenase-2 expression in resectable pancreatic cancer

by Hermanova, Marketa, Karasek, Petr, Tomasek, Jiri, Lenz, Jiri, Jarkovsky, Jiri, Dite, Petr
Published 2010

Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC

by Hebart, Holger, Kiehl, Michael, Tomasek, Jiri, Csoszi, Tibor, Koukakis, Reija, Kafatos, George, Kuhn, Anja, Bjorklof, Katja, Demonty, Gaston, Buchler, Tomas
Published in Adv Ther (2019)

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

by Slavicek, Lubomir, Pavlik, Tomas, Tomasek, Jiri, Bortlicek, Zbynek, Buchler, Tomas, Melichar, Bohuslav, Vyzula, Rostislav, Prausova, Jana, Finek, Jindrich, Majek, Ondrej, Dusek, Ladislav
Published 2014

Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review

by Trojan, Jörg, Mineur, Laurent, Tomášek, Jiří, Rouleau, Etienne, Fabian, Pavel, de Maglio, Giovanna, García-Alfonso, Pilar, Aprile, Giuseppe, Taylor, Aliki, Kafatos, George, Downey, Gerald, Terwey, Jan-Henrik, van Krieken, J. Han
Published in PLoS One (2015)

Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review

by Han van Krieken, J., Kafatos, George, Bennett, James, Mineur, Laurent, Tomášek, Jiří, Rouleau, Etienne, Fabian, Pavel, De Maglio, Giovanna, García-Alfonso, Pilar, Aprile, Giuseppe, Parkar, Parijan, Downey, Gerald, Demonty, Gaston, Trojan, Jörg
Published in BMC Cancer (2017)

Everolimus in advanced, progressive, well‐differentiated, non‐functional neuroendocrine tumors: RADIANT‐4 lung subgroup analysis

by Fazio, Nicola, Buzzoni, Roberto, Delle Fave, Gianfranco, Tesselaar, Margot E., Wolin, Edward, Van Cutsem, Eric, Tomassetti, Paola, Strosberg, Jonathan, Voi, Maurizio, Bubuteishvili‐Pacaud, Lida, Ridolfi, Antonia, Herbst, Fabian, Tomasek, Jiri, Singh, Simron, Pavel, Marianne, Kulke, Matthew H., Valle, Juan W., Yao, James C.
Published in Cancer Sci (2017)

Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab

by Fuchs, Charles S, Tabernero, Josep, Tomášek, Jiří, Chau, Ian, Melichar, Bohuslav, Safran, Howard, Tehfe, Mustapha A, Filip, Dumitru, Topuzov, Eldar, Schlittler, Luis, Udrea, Anghel Adrian, Campbell, William, Brincat, Stephen, Emig, Michael, Melemed, Symantha A, Hozak, Rebecca R, Ferry, David, Caldwell, C William, Ajani, Jaffer A
Published in Br J Cancer (2016)

Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data

by Fuchs, Charles S., Muro, Kei, Tomasek, Jiri, Van Cutsem, Eric, Cho, Jae Yong, Oh, Sang-Cheul, Safran, Howard, Bodoky, György, Chau, Ian, Shimada, Yasuhiro, Al-Batran, Salah-Eddin, Passalacqua, Rodolfo, Ohtsu, Atsushi, Emig, Michael, Ferry, David, Chandrawansa, Kumari, Hsu, Yanzhi, Sashegyi, Andreas, Liepa, Astra M., Wilke, Hansjochen
Published in J Gastric Cancer (2017)

Everolimus for the treatment of advanced, nonfunctional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

by Yao, James C, Fazio, Nicola, Singh, Simron, Buzzoni, Roberto, Carnaghi, Carlo, Wolin, Edward, Tomasek, Jiri, Raderer, Markus, Lahner, Harald, Voi, Maurizio, Pacaud, Lida Bubuteishvili, Rouyrre, Nicolas, Sachs, Carolin, Valle, Juan W, Fave, Gianfranco Delle, Van Cutsem, Eric, Tesselaar, Margot, Shimada, Yasuhiro, Oh, Do-Youn, Strosberg, Jonathan, Kulke, Matthew H, Pavel, Marianne E
Published in Lancet (2015)